India’s Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as the country grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic. The treatment candidate, ZRC-3308, was earlier shown to reduce lung damage during animal trials, the drugmaker said, adding it was found to be safe and well-tolerated. The therapy is a cocktail of two monoclonal antibodies, which mimic natural antibodies that the body generates to fight infection. "At this juncture, there is a critical need to explore safer and more efficacious treatments to combat COVID," Zydus Cadila's managing direct
Hence then, the article about india s zydus cadila seeks human trial approval for covid 19 antibody cocktail was published today ( ) and is available onGulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( India’s Zydus Cadila seeks human trial approval for COVID-19 antibody cocktail )